1. Home
  2. HKD vs RCKT Comparison

HKD vs RCKT Comparison

Compare HKD & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HKD

AMTD Digital Inc. (every five of which represent two)

HOLD

Current Price

$1.81

Market Cap

499.7M

Sector

Finance

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.91

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HKD
RCKT
Founded
2003
1999
Country
France
United States
Employees
N/A
202
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
499.7M
534.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
HKD
RCKT
Price
$1.81
$3.91
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$29.73
AVG Volume (30 Days)
194.8K
4.2M
Earning Date
02-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$64.28
P/E Ratio
$14.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$2.19
52 Week High
$5.47
$8.26

Technical Indicators

Market Signals
Indicator
HKD
RCKT
Relative Strength Index (RSI) 66.62 49.23
Support Level $1.58 $2.99
Resistance Level $1.88 $4.08
Average True Range (ATR) 0.10 0.28
MACD 0.02 0.02
Stochastic Oscillator 85.39 38.43

Price Performance

Historical Comparison
HKD
RCKT

About HKD AMTD Digital Inc. (every five of which represent two)

AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment; hotel operations, hospitality and VIP services segment; media and entertainment services segment; and Strategic investments. The company generates maximum revenue from Digital solutions services segment, which provides its institutional and corporate clients with exclusive, paid access to enhance their investor communication, investor relations and corporate communication to potentially maximize their valuation, as well as providing digital solution services. Geographically, the company generates revenue from China, Hong Kong, Europe, Americas and Southeast Asia.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: